Medicamen Biotech Limited (BOM:531146)
India · Delayed Price · Currency is INR 303.00
+5.50 (1.85%)
At close: Mar 4, 2026
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 3.75 billion as of March 5, 2026. Its market cap has decreased by -36.83% in one year.
Market Cap
3.75B
Enterprise Value
3.70B
Revenue
1.72B
Ranking
n/a
PE Ratio
50.43
Stock Price
303.00
Market Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 3.75B, an increase of 3,353.81%. That is a compound annual growth rate of 18.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 3.75B | -18.83% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kilitch Drugs (India) | 5.47B |
| Jenburkt Pharmaceuticals | 4.41B |
| Albert David | 3.93B |
| Medico Remedies | 3.54B |
| Amanta Healthcare | 3.44B |
| ZIM Laboratories | 3.32B |
| Trident Lifeline | 3.20B |
| Everest Organics | 2.88B |